BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33672989)

  • 1. Bi-Functional Radiotheranostics of
    Huang YS; Hsu WC; Lin CH; Lo SN; Cheng CN; Lin MS; Lee TW; Chang CH; Lan KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorocytosine combined with Fcy-hEGF fusion protein targets EGFR-expressing cancer cells.
    Lan KH; Shih YS; Chang CA; Yen SH; Lan KL
    Biochem Biophys Res Commun; 2012 Nov; 428(2):292-7. PubMed ID: 23085230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affibody-conjugated 5-fluorouracil prodrug system preferentially targets and inhibits HER2-expressing cancer cells.
    Lan KH; Tsai CL; Chen YY; Lee TL; Pai CW; Chao Y; Lan KL
    Biochem Biophys Res Commun; 2021 Dec; 582():137-143. PubMed ID: 34710829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
    BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
    Bailey KE; Costantini DL; Cai Z; Scollard DA; Chen Z; Reilly RM; Vallis KA
    J Nucl Med; 2007 Sep; 48(9):1562-70. PubMed ID: 17704253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
    Cai Z; Chen Z; Bailey KE; Scollard DA; Reilly RM; Vallis KA
    J Nucl Med; 2008 Aug; 49(8):1353-61. PubMed ID: 18632822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
    Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
    J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.
    Park JI; Cao L; Platt VM; Huang Z; Stull RA; Dy EE; Sperinde JJ; Yokoyama JS; Szoka FC
    Mol Pharm; 2009; 6(3):801-12. PubMed ID: 19265397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib.
    He P; Li G
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):341-8. PubMed ID: 23748900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
    Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
    Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
    Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
    Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
    Hu M; Scollard D; Chan C; Chen P; Vallis K; Reilly RM
    Nucl Med Biol; 2007 Nov; 34(8):887-96. PubMed ID: 17998090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.
    Li L; Zhang CL; Kang L; Wang RF; Yan P; Zhao Q; Yin L; Guo FQ
    Cancer Biother Radiopharm; 2015 Oct; 30(8):342-8. PubMed ID: 26382009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
    Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
    Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
    Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
    Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme Prodrug Therapy with Photo-Cross-Linkable Anti-EGFR Affibodies Conjugated to Upconverting Nanoparticles.
    Roy S; Curry SD; Corbella Bagot C; Mueller EN; Mansouri AM; Park W; Cha JN; Goodwin AP
    ACS Nano; 2022 Oct; 16(10):15873-15883. PubMed ID: 36129781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymes Photo-Cross-Linked to Live Cell Receptors Retain Activity and EGFR Inhibition after Both Internalization and Recycling.
    Roy S; Brasino M; Beirne JM; Harguindey A; Chapnick DA; Liu X; Cha JN; Goodwin AP
    Bioconjug Chem; 2020 Jan; 31(1):104-112. PubMed ID: 31840981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor activity of the recombinant rClone30-CD/5-FC system].
    Lu Z; Zhang TY; Han MM; Bai FL; Wu W; Tian GY; Ren GP; Li DS
    Yao Xue Xue Bao; 2013 Feb; 48(2):261-8. PubMed ID: 23672024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.
    Simpson GR; Han Z; Liu B; Wang Y; Campbell G; Coffin RS
    Cancer Res; 2006 May; 66(9):4835-42. PubMed ID: 16651439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.